» Articles » PMID: 21228034

Cardiac Iron and Cardiac Disease in Males and Females with Transfusion-dependent Thalassemia Major: a T2* Magnetic Resonance Imaging Study

Abstract

Background: It has been repeatedly reported that female patients with thalassemia major survive longer than males and that the difference is due to a lower rate of cardiac disease in females.

Design And Methods: We compared the cardiac iron load as measured by T2* magnetic resonance imaging in 776 patients (370 males) examined at the National Research Council as part of an Italian cooperative study. We also established normal left ventricular ejection fraction values for our population.

Results: The prevalence of cardiac disease was higher in males than in females (105 males versus 69 females; P < 0.0001). Cardiac T2* was significantly lower in patients with heart dysfunction (P < 0.0001), but no difference was observed according to sex. Twenty males and five females had a history of cardiac arrhythmias. Their cardiac T2* was not significantly lower than that of patients without arrhythmias (24 ms versus 26 ms; P = 0.381), nor was there a difference between sexes. Liver T2* was significantly lower in males and females with heart dysfunction compared to those without. Ferritin levels were higher in patients of both sexes with heart dysfunction without significant differences between males and females. Conclusions Males and females are at the same risk of accumulating iron in their hearts, but females tolerate iron toxicity better, possibly as an effect of reduced sensitivity to chronic oxidative stress.

Citing Articles

Biatrial and Biventricular Reference Ranges Based on Cardiac Magnetic Resonance in Sickle Cell Disease Patients Without Heart Damage.

Pistoia L, Meloni A, Positano V, Quota A, Corigliano E, Messina G Diagnostics (Basel). 2025; 14(24.

PMID: 39767177 PMC: 11674925. DOI: 10.3390/diagnostics14242816.


Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients.

Meloni A, Pistoia L, Ricchi P, Longo F, Cecinati V, Sorrentino F J Clin Med. 2024; 13(16).

PMID: 39200932 PMC: 11355279. DOI: 10.3390/jcm13164791.


Association between Epicardial Adipose Tissue and Atrial Fibrillation in Patients with Transfusion-Dependent β-Thalassemia.

Malagu M, Tonet E, Orazio G, Longo F, De Raffele M, Sirugo P J Clin Med. 2024; 13(12).

PMID: 38930000 PMC: 11205093. DOI: 10.3390/jcm13123471.


Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.

Meloni A, Pistoia L, Ricchi P, Longo F, Cecinati V, Sorrentino F Radiol Med. 2024; 129(6):879-889.

PMID: 38683500 DOI: 10.1007/s11547-024-01821-y.


Multiparametric Cardiac Magnetic Resonance Assessment in Sickle Beta Thalassemia.

Pistoia L, Meloni A, Positano V, Longo F, Borsellino Z, Spasiano A Diagnostics (Basel). 2024; 14(7).

PMID: 38611604 PMC: 11012026. DOI: 10.3390/diagnostics14070691.


References
1.
Positano V, Pepe A, Santarelli M, Ramazzotti A, Meloni A, De Marchi D . Multislice multiecho T2* cardiac magnetic resonance for the detection of heterogeneous myocardial iron distribution in thalassaemia patients. NMR Biomed. 2009; 22(7):707-15. DOI: 10.1002/nbm.1382. View

2.
Cerqueira M, Weissman N, Dilsizian V, Jacobs A, Kaul S, Laskey W . Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002; 18(1):539-42. View

3.
Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini M, Del Vecchio G . Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89(10):1187-93. View

4.
Chouliaras G, Yiannoutsos C, Berdoukas V, Ladis V . Cardiac related death in thalassaemia major: time trend and risk factors in a large Greek Unit. Eur J Haematol. 2009; 82(5):381-7. DOI: 10.1111/j.1600-0609.2009.01218.x. View

5.
Kirk P, Roughton M, Porter J, Walker J, Tanner M, Patel J . Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009; 120(20):1961-8. PMC: 2784198. DOI: 10.1161/CIRCULATIONAHA.109.874487. View